Search

everythinglearnresearchcommunity

for

Search:↓

Caffeine may help reduce stress-induced hair loss.

Enzyme purified and characterized for minoxidil sulphation in rat liver.

Placenta products might help with hair loss, but more research is needed.

Grape seed oil improved hair quality the most, followed by rosehip and safflower seed oils, and reduced damage from shampoo.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Combining minoxidil with MS injections leads to better hair regrowth in men.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Hair follicle regeneration needs special conditions and young cells.

Hair follicle stem cells are important for maintaining healthy skin and interact with many signals.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Creating fully functional artificial skin for chronic wounds is still very challenging.

Nanotechnology improves minoxidil treatment for hair loss.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

Reducing FOXA2 in skin cells lowers their ability to grow hair.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

The ingredients could help prevent hair loss by promoting hair growth and increasing VEGF secretion.